Form: S-3

Registration statement under Securities Act of 1933

May 23, 2025

Documents

Exhibit 107

Calculation of Filing Fee Table

Form S-3

(Form Type)

Benitec Biopharma Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities

 

                 
     Security
Type		  

Security

Class

Title

   Fee
Calculation
or Carry
Forward
Rule		   Amount
Registered(1)(2) 		  Proposed
Maximum
Offering
Price Per
Unit(3) 		 

Proposed

Maximum
Aggregate
Offering

Price(3)

  

Fee

Rate

   Amount of
Registration
Fee
                 
Fees to Be Paid   Equity   Common Stock, par value $0.0001 per share   457(c)   900,000   $13.82   $12,433,500   0.0001531   $1,903.57
           
    Total Offering Amounts     $12,397,500      
           
    Total Fees Previously Paid          
           
    Total Fee Offsets         —
           
    Net Fee Due               $1,903.57

 

(1)

Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), there is also being registered hereby an indeterminate number of shares that may be issued and resold resulting from stock splits, stock dividends or similar transactions.

 

(2)

The amount of shares of common stock registered consists of 900,000 shares of common stock of the registrant held by the selling stockholders.

 

(3)

Estimated solely for the purpose of calculating the registration fee, based on the average of the high and low prices of the shares of common stock of the registrant on the Nasdaq Capital Market on May 16, 2025 (such date being within five business days of the date that this registration statement was first filed with the U.S. Securities and Exchange Commission, in accordance with Rule 457(c) under the Securities Act).